BRIEF-CSPC Pharmaceutical Group'S Unit Enters Agreement With I-Mab Biopharma (Shanghai) Co
Dec 17 (Reuters) - CSPC Pharmaceutical Group Ltd:
* UNIT ENTERED INTO AN AGREEMENT WITH I-MAB BIOPHARMA (SHANGHAI) CO., LTD.
* CSPC BAIKE AGREED TO PAY UPFRONT PAYMENT OF RMB15 MILLION & DEVELOPMENT MILESTONE PAYMENTS OF UP TO RMB135 MILLION TO I-MAB
* DEAL FOR LICENSING & COMMERCIALIZATION OF LONG-ACTING RECOMBINANT GLP-1 FC FUSION PROTEIN (TG103) FOR INJECTION DEVELOPED BY I-MAB Source text for Eikon: Further company coverage: